ClearPoint Neuro Inc. (CLPT)
NASDAQ: CLPT
· Real-Time Price · USD
19.57
-0.17 (-0.86%)
At close: Sep 26, 2025, 11:06 AM
-0.86% (1D)
| Bid | 19.51 |
| Market Cap | 556.32M |
| Revenue (ttm) | 33.59M |
| Net Income (ttm) | -22.22M |
| EPS (ttm) | -0.8 |
| PE Ratio (ttm) | -24.46 |
| Forward PE | -28.35 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 19.58 |
| Volume | 583,386 |
| Avg. Volume (20D) | 665,304 |
| Open | 19.00 |
| Previous Close | 19.74 |
| Day's Range | 18.84 - 20.37 |
| 52-Week Range | 9.76 - 21.57 |
| Beta | 0.89 |
| Ex-Dividend Date | n/a |
About CLPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsClearPoint Neuro Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-12.46%
ClearPoint Neuro shares are trading lower after th...
Unlock content with
Pro Subscription
5 months ago
+10.09%
ClearPoint Neuro shares are trading higher after Stifel raised its price target on the stock from $19 to $25 and maintained a Buy rating.
2 months ago · accessnewswire.com
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025SOLANA BEACH, CALIFORNIA / ACCESS Newswire / July 23, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation ...
